GT Biopharma, Inc.
GTBP
$1.14
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -43.47% | -75.88% | -71.72% | -59.92% | -48.54% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5,694.44% | 156.41% | 123.81% | 552.63% | -62.50% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -23.13% | -73.11% | -69.89% | -57.89% | -48.58% |
|
|
|||||
| Total Current Assets | -23.13% | -73.11% | -69.89% | -57.89% | -48.58% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -23.13% | -73.18% | -70.00% | -58.14% | -48.93% |
|
|
|||||
| Total Accounts Payable | -19.98% | -25.93% | -10.98% | -34.21% | -50.96% |
| Total Accrued Expenses | -65.55% | 17.55% | 50.38% | 81.71% | 44.44% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 17.33% | -68.02% | -76.05% | -- | -- |
| Total Other Current Liabilities | 17.33% | -68.02% | -76.05% | -- | -- |
| Total Current Liabilities | -38.63% | -20.91% | -11.02% | -8.41% | -22.38% |
|
|
|||||
| Total Current Liabilities | -38.63% | -20.91% | -11.02% | -8.41% | -22.38% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -38.63% | -20.91% | -11.02% | -24.11% | -41.09% |
|
|
|||||
| Common Stock & APIC | 0.99% | 0.78% | 0.58% | 0.64% | 0.74% |
| Retained Earnings | -1.38% | -1.71% | -1.93% | -1.82% | -1.68% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -48.07% | -118.47% | -122.35% | -79.05% | -53.18% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 195,600.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 195,600.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -48.07% | -118.47% | -122.35% | -79.05% | -53.18% |
| Total Preferred Equity | 195,600.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.55% | -118.45% | -122.34% | -79.04% | -53.18% |
|
|
|||||